View Author

Wagner, E.R.

( E.R. Wagner)


patient jejuni ganglioside antibody serum reactivity jejuni lps campylobacter serum samples enteriti sample ganglioside mimics campylobacter jejuni mfs patients control antiganglioside neuropathy epitope group binding miller fisher syndrome structure lipopolysaccharide van doorn antibody reactivity campylobacter jejuni lipopolysaccharides mimic response gbs patients toxin mimicry gq 1b symptom infection panel fisher syndrome enteritis patients guillain-barryndrome gq 1b group neuropathy patients 1-like specificity presence jacob glycolipid feature antiganglioside specificity antiganglioside antibodies table oculomotor symptoms miller lps fractions ct binding gm 1 group doorn strain penner anti-gm 1 antibodies control enteritis patients method anti-gm campylobacter jejuni enteritis 10 serum samples anti-gq anti-lp study ganglioside-like epitopes antibody response neurol willison fraction endtz lectin immun result difference ganglioside-like oculomotor motor neuropathy patients




1 Most Recent Publications

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients (Article)
Ang, C.W. Laman, J.D. Willison, H.J. Wagner, E.R. Endtz, H.P. Klerk, M.A. de Tio-Gillen, A.P. Braak, N.P.W.C.J. van den Jacobs, B.C. Doorn, P.A. van
2002-01-01